Evofem Biosciences, Inc.
EVFM
$0.0097
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 346.00K | 127.00K | 202.00K | -- | -- |
| Total Receivables | 1.15M | 9.83M | 5.39M | 4.62M | 4.31M |
| Inventory | 2.26M | 1.58M | 1.46M | 1.06M | 1.31M |
| Prepaid Expenses | 162.00K | 1.85M | 627.00K | 488.00K | 314.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.95M | 2.42M | 892.00K | 1.05M | 997.00K |
| Total Current Assets | 5.87M | 13.61M | 8.58M | 7.21M | 6.92M |
|
|
|||||
| Total Current Assets | 5.87M | 13.61M | 8.58M | 7.21M | 6.92M |
| Net Property, Plant & Equipment | 481.00K | 547.00K | 1.31M | 1.30M | 1.26M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 6.49M | 9.60M | 14.02M | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 36.00K | 36.00K | 36.00K | 36.00K | 35.00K |
| Total Assets | 12.88M | 23.79M | 23.94M | 8.55M | 8.22M |
|
|
|||||
| Total Accounts Payable | 11.22M | 16.17M | 16.86M | 16.03M | 16.29M |
| Total Accrued Expenses | 5.89M | 9.00M | 8.35M | 8.03M | 7.84M |
| Short-term Debt | 45.67M | 15.11M | 14.45M | 13.64M | 13.25M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 48.00K | 30.85M | 30.32M | 29.76M | 29.16M |
| Total Finance Division Other Current Liabilities | 8.02M | 9.31M | 6.31M | 5.72M | 7.70M |
| Total Other Current Liabilities | 8.02M | 9.31M | 6.31M | 5.72M | 7.70M |
| Total Current Liabilities | 70.85M | 80.45M | 76.29M | 73.18M | 74.24M |
|
|
|||||
| Total Current Liabilities | 70.85M | 80.45M | 76.29M | 73.18M | 74.24M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 45.67M | 15.11M | 14.45M | 13.64M | 13.25M |
| Capital Leases | 5.00K | 7.00K | 10.00K | 1.00K | 4.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.82M | 9.81M | 13.78M | -- | -- |
| Total Liabilities | 77.68M | 90.26M | 90.07M | 73.18M | 74.24M |
|
|
|||||
| Common Stock & APIC | 829.11M | 829.04M | 825.44M | 823.72M | 823.41M |
| Retained Earnings | -896.71M | -897.66M | -894.62M | -892.25M | -893.56M |
| Treasury Stock & Other | -1.98M | -2.63M | -1.71M | -781.00K | -525.00K |
| Total Common Equity | -69.59M | -71.26M | -70.89M | -69.32M | -70.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 4.79M | 4.78M | 4.76M | 4.69M | 4.64M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 4.79M | 4.78M | 4.76M | 4.69M | 4.64M |
|
|
|||||
| Total Common Equity | -69.59M | -71.26M | -70.89M | -69.32M | -70.67M |
| Total Preferred Equity | 4.79M | 4.78M | 4.76M | 4.69M | 4.64M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -64.80M | -66.48M | -66.13M | -64.63M | -66.03M |
|
|
|||||